FDA asks Novavax for post-marketing data of its Covid vaccine, delaying approval

The FDA has asked Novavax to commit to producing post-marketing data of its Covid vaccine, the clearest example yet that the goalposts have changed for vaccine makers under HHS Secretary Robert F. Kennedy Jr.’s leadership ...